Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial cell wall components and surface structures represent a broad class of essential structural elements found in bacteria and fungi that are critical for maintaining cellular integrity and mediating interactions with the host environment [Sarkar et al., 2021, PubMed]. In bacteria, the cell wall is primarily composed of peptidoglycan, a complex polymer that provides mechanical strength to withstand high internal osmotic pressure; in Gram-negative species, this is further protected by an outer membrane containing lipopolysaccharides (LPS) [Raetz & Whitfield, 2002, PubMed]. Fungal cell walls differ by utilizing chitin and beta-glucans to provide rigidity [Garcia-Rubio et al., 2020, PubMed]. Because these structures are unique to microbes and absent in mammalian cells, they serve as primary targets for many of the most effective antimicrobial agents, including beta-lactams, glycopeptides, and echinocandins [StatPearls, 2023]. These drugs typically work by inhibiting the enzymes responsible for synthesizing or cross-linking these structural polymers, leading to cell lysis and death [Sarkar et al., 2021, PubMed]. Additionally, these surface structures are often the first point of contact for the host immune system, acting as potent antigens or pathogen-associated molecular patterns (PAMPs) that drive the inflammatory response during infection [NIH, 2022].
Inhibition of peptidoglycan synthesis and cross-linking, inhibition of beta-glucan synthesis, and disruption of outer membrane integrity [StatPearls, 2023].
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cell wall components and surface structures.